📢 We have launched a new symbol for Cancer Cachexia!! 📢 Our call to unite, act, and raise awareness. Join our movement. #CCAD2025#CachexiaWastingMatters 💙🧡🩵 Help us spread the word! September 26th, 2025 - First-ever Cancer Cachexia Awareness Day!!
We are delighted to announce the speakers for the most important sessions at the @CancerCachexia Conference - the "Next Gen" sessions, that are focused on pre- and post-doctoral trainees. Registration closes August 1. Don't miss out! https://t.co/BksofSsNLr
The first morning of the @CancerCachexia Conference will be focused on how the tumor microenvironment and metastasis drive, and impact, cachexia from basic science and clinical perspectives. The early-bird registration deadline is June 30th: https://t.co/BksofStlAZ
An updated program of incredible speakers is now posted for the 2025 @CancerCachexia Conference: https://t.co/g4Gq6WBKKw
Don't miss the early-bird registration deadline - June 30
Presented at #ASCO25:
A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results: https://t.co/j3kWJDjuVz
@ASCO
🚨 New in JCO: IL-6R blockade w/tocilizumab protects muscle in pts w/ #pancreaticcancer on gem/nab-paclitaxel, w/ no benefit for PFS, OS6mos. Precision cachexia therapy? Grateful for 9-yr collab w/Herlev team. #cancercachexia correlatives funded by @theNCI
https://t.co/sAML85psFG
Mark your calendars!
The 18th International #SCWDConference is happening on 11–13 December 2025 in Rome.
Join global experts in 18th International Conference on #Cachexia, #Sarcopenia & Muscle Wasting as we explore the latest research & advancements.
Stay tuned for updates.
🚨🚨Hot off the press @NEJM
In a randomized Ph II Ponsegromab, an anti-GDF15 mAB, increased weight gain, overall physical activity and reduced cachexia symptoms in patients with #cachexia and ⬆️ GDF-15
https://t.co/1oYe8OWT2O
Great to meet Marianne and @baillert to compare notes on Norwegian and UK experiences and talk all things parenteral nutrition in advanced cancer #ESPEN2024
The Education Committee of @CancerCachexia Society invites you to join us June 12 at 12:00 pm EDT with Abigail Newell, Cancer Support Community, and Barry Laird, CCS Clinical Trials Advisory Board. Seminars are open to everyone, please share! See https://t.co/9FZqW5DXH1 for link.